GRDX • NASDAQ
GridAI Technologies Corp.
$4.80
Stock Details
| Market Cap | 34,229,390 |
|---|---|
| Day Change | 0.68 (16.50%) |
| Volume | 207,498 |
| Avg Volume | 100,973 |
| Price Range | 1.87-6.93 |
Overview
| Country | GB |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
Company Profile
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Financial Overview
| 52 Week High | 6.9291 |
|---|---|
| 52 Week High Date | 2026-06-01 |
| 52 Week Low | 1.87 |
| 52 Week Low Date | 2026-03-24 |
| 10D Avg Trading Vol | 0.09516 |
| YTD Price Return Daily | -10.515 |
| MTD Price Return Daily | 13.2537 |
Cash Flow
| TTM/Share | |
|---|---|
| Annual/Share | -1.3501 |
| Quarterly/Share | -1.1747 |
Price-to-Earnings
| Annual Ratio | 0.1712 |
|---|---|
| Quarterly Ratio | 0.1625 |
| TTM |
Revenue
| 3Y Growth | |
|---|---|
| 5Y Growth | |
| Annual/Share | |
| TTM/Share | |
| 5Y Share Growth |
Earnings Per Share
| Annual | -3.9541 |
|---|---|
| 3Y Growth | |
| 5Y Growth | |
| Quarterly YOY Growth |
Price-to-Book
| Ratio | 2.1683 |
|---|---|
| Annual Ratio | 0.6608 |
| TTM | 2.2324 |